| Absorption |
| Blood-Brain Barrier | BBB- | 0.9954 |
| Human Intestinal Absorption | HIA- | 0.9059 |
| Caco-2 Permeability | Caco2- | 0.8956 |
| P-glycoprotein Substrate | Substrate | 0.6253 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9374 |
| Non-inhibitor | 0.9905 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9485 |
| Distribution |
| Subcellular localization | Lysosome | 0.4919 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7694 |
| CYP450 2D6 Substrate | Non-substrate | 0.8450 |
| CYP450 3A4 Substrate | Non-substrate | 0.5133 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9046 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9187 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9295 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9026 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8802 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9600 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9993 |
| Non-inhibitor | 0.9223 |
| AMES Toxicity | Non AMES toxic | 0.9193 |
| Carcinogens | Non-carcinogens | 0.6267 |
| Fish Toxicity | High FHMT | 0.9535 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.8693 |
| Honey Bee Toxicity | Low HBT | 0.7501 |
| Biodegradation | Not ready biodegradable | 0.9890 |
| Acute Oral Toxicity | IV | 0.6160 |
| Carcinogenicity (Three-class) | Non-required | 0.6867 |